Hanover, Germany

Fedor Heidenreich

This inventor holds 1 USPTO granted patent. Top assignee: Euroimmun Medizinische Labordiagnostika Ag. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fedor Heidenreich: Innovator in Neurological Disease Diagnosis

Introduction

Fedor Heidenreich is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of neurological diseases. His innovative approach has the potential to enhance the accuracy and efficiency of disease detection.

Latest Patents

Fedor Heidenreich holds 1 patent related to the diagnosis of a neurological disease. This patent describes a method for diagnosing the disease by detecting an autoantibody that binds to the alpha 3 subunit of the human neuronal Na(+)/K(+) ATPase. The invention includes various components such as isolated and recombinant polypeptides, pharmaceutical compositions, and diagnostic devices that utilize this polypeptide for disease treatment and diagnosis.

Career Highlights

Heidenreich is currently associated with Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. His work at Euroimmun has allowed him to focus on innovative solutions that address critical health challenges.

Collaborations

Heidenreich collaborates with talented professionals in his field, including Lars Komorowski and Madeleine Scharf. These collaborations enhance the research and development efforts at Euroimmun, fostering an environment of innovation and discovery.

Conclusion

Fedor Heidenreich's contributions to the diagnosis of neurological diseases exemplify the impact of innovation in medical science. His work not only advances diagnostic methods but also holds promise for improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…